SEC Comment Letter for Aspira Women's Health Inc. (AWHL) (CIK 0000926617) (AWHL) — Aug 4, 2017
Aspira Women's Health Inc. (AWHL) (CIK 0000926617)
Date: Aug. 4, 2017 · CIK: 0000926617 · Accession: 0000000000-17-027564
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-34810
Letter
August 4, 2017 Via E -mail Ms. Valerie Palmieri President and Chief Executive Officer Vermillion, Inc. 12117 Bee Caves R oad, Building Three, Suite 100 Austin, T X 78738
Re: Vermillion, Inc. Form 10-K for the Year Ended December 31 , 2016 Filed March 31, 2017 File No. 001-34810
Dear Ms. Palmieri :
We have completed our review of your filings . We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff .
Sincerely,
/s/ Sharon M. Blume
Show Raw Text
Mail Stop 4 546 August 4, 2017 Via E -mail Ms. Valerie Palmieri President and Chief Executive Officer Vermillion, Inc. 12117 Bee Caves R oad, Building Three, Suite 100 Austin, T X 78738 Re: Vermillion, Inc. Form 10-K for the Year Ended December 31 , 2016 Filed March 31, 2017 File No. 001-34810 Dear Ms. Palmieri : We have completed our review of your filings . We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff . Sincerely, /s/ Sharon M. Blume Sharon M. Blume Accounting Branch Chief Office of Healthcare and Insurance